These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29051736)

  • 21. The therapeutic potential of second and third generation CB
    Cinar R; Iyer MR; Kunos G
    Pharmacol Ther; 2020 Apr; 208():107477. PubMed ID: 31926199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
    Fulp A; Zhang Y; Bortoff K; Seltzman H; Snyder R; Wiethe R; Amato G; Maitra R
    Bioorg Med Chem; 2016 Mar; 24(5):1063-70. PubMed ID: 26827137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice.
    Chen B; Hu N
    Braz J Med Biol Res; 2017 May; 50(6):e6141. PubMed ID: 28492810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications.
    Nagappan A; Shin J; Jung MH
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes.
    Perwitz N; Wenzel J; Wagner I; Büning J; Drenckhan M; Zarse K; Ristow M; Lilienthal W; Lehnert H; Klein J
    Diabetes Obes Metab; 2010 Feb; 12(2):158-66. PubMed ID: 19895638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.
    Seltzman HH; Shiner C; Hirt EE; Gilliam AF; Thomas BF; Maitra R; Snyder R; Black SL; Patel PR; Mulpuri Y; Spigelman I
    J Med Chem; 2016 Aug; 59(16):7525-43. PubMed ID: 27482723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
    Zhang H; Lund DM; Ciccone HA; Staatz WD; Ibrahim MM; Largent-Milnes TM; Seltzman HH; Spigelman I; Vanderah TW
    Pain; 2018 Sep; 159(9):1814-1823. PubMed ID: 29781960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
    Simon V; Cota D
    Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral CB1R as a modulator of metabolic inflammation.
    Han JH; Kim W
    FASEB J; 2021 Apr; 35(4):e21232. PubMed ID: 33715173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
    Pavon FJ; Bilbao A; Hernández-Folgado L; Cippitelli A; Jagerovic N; Abellán G; Rodríguez-Franco MA; Serrano A; Macias M; Gómez R; Navarro M; Goya P; Rodríguez de Fonseca F
    Neuropharmacology; 2006 Aug; 51(2):358-66. PubMed ID: 16750544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
    Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.
    Janero DR
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):17-29. PubMed ID: 22335400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB
    Iyer MR; Cinar R; Katz A; Gao M; Erdelyi K; Jourdan T; Coffey NJ; Pacher P; Kunos G
    J Med Chem; 2017 Feb; 60(3):1126-1141. PubMed ID: 28085283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.
    Tam J; Szanda G; Drori A; Liu Z; Cinar R; Kashiwaya Y; Reitman ML; Kunos G
    Mol Metab; 2017 Oct; 6(10):1113-1125. PubMed ID: 29031713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development.
    Nguyen T; Thomas BF; Zhang Y
    Curr Top Med Chem; 2019; 19(16):1418-1435. PubMed ID: 31284863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists.
    Sharma MK; Murumkar PR; Kanhed AM; Giridhar R; Yadav MR
    Eur J Med Chem; 2014 May; 79():298-339. PubMed ID: 24747288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.
    Laprairie RB; Kulkarni PM; Deschamps JR; Kelly MEM; Janero DR; Cascio MG; Stevenson LA; Pertwee RG; Kenakin TP; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2017 Jun; 8(6):1188-1203. PubMed ID: 28103441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
    Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB
    Liu Z; Iyer MR; Godlewski G; Jourdan T; Liu J; Coffey NJ; Zawatsky CN; Puhl HL; Wess J; Meister J; Liow JS; Innis RB; Hassan SA; Lee YS; Kunos G; Cinar R
    ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1175-1187. PubMed ID: 34151207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet-Induced Obesity in Cannabinoid-2 Receptor Knockout Mice and Cannabinoid Receptor 1/2 Double-Knockout Mice.
    Alshaarawy O; Kurjan E; Truong N; Olson LK
    Obesity (Silver Spring); 2019 Mar; 27(3):454-461. PubMed ID: 30699233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.